These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30014300)

  • 41. Venous thromboembolism associated with central venous catheters in patients with cancer: From pathophysiology to thromboprophylaxis, areas for future studies.
    Debourdeau P; Lamblin A; Debourdeau T; Marcy PY; Vazquez L
    J Thromb Haemost; 2021 Nov; 19(11):2659-2673. PubMed ID: 34363736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study.
    Donadini MP; Dentali F; Pegoraro S; Pomero F; Brignone C; Guasti L; Steidl L; Ageno W
    Vasc Med; 2017 Dec; 22(6):518-524. PubMed ID: 28732457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study.
    Napolitano M; Valore L; Malato A; Saccullo G; Vetro C; Mitra ME; Fabbiano F; Mannina D; Casuccio A; Lucchesi A; Del Principe MI; Candoni A; Di Raimondo F; Siragusa S
    Leuk Lymphoma; 2016; 57(1):116-9. PubMed ID: 25944377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm.
    Goltz JP; Schmid JS; Ritter CO; Knödler P; Petritsch B; Kirchner J; Hahn D; Kickuth R
    J Vasc Access; 2012; 13(1):79-85. PubMed ID: 21786241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
    Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
    Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.
    Sartori M; Favaretto E; Migliaccio L; Guazzaloca G; Legnani C; Palareti G; Cosmi B
    Thromb Res; 2016 Mar; 139():154-7. PubMed ID: 26916314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Catheter-related thrombosis: lifeline or a pain in the neck?
    Kamphuisen PW; Lee AY
    Hematology Am Soc Hematol Educ Program; 2012; 2012():638-44. PubMed ID: 23233646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2).
    Davies GA; Lazo-Langner A; Gandara E; Rodger M; Tagalakis V; Louzada M; Corpuz R; Kovacs MJ
    Thromb Res; 2018 Feb; 162():88-92. PubMed ID: 28416213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.
    den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV
    Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
    Hull RD; Pineo GF
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
    Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
    Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catheter-related thrombosis in cancer patients.
    Murray J; Precious E; Alikhan R
    Br J Haematol; 2013 Sep; 162(6):748-57. PubMed ID: 23848991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandalà M; Papaldo P; Fabi A; Ciccarese M; Cuppone F; Cecere FL; Nuzzo C; Terzoli E; Cognetti F
    Chest; 2006 Dec; 130(6):1808-16. PubMed ID: 17167001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation.
    Drakos PE; Nagler A; Or R; Gillis S; Slavin S; Eldor A
    Cancer; 1992 Oct; 70(7):1895-8. PubMed ID: 1326397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study.
    Debourdeau P; Espié M; Chevret S; Gligorov J; Elias A; Dupré PF; Desseaux K; Kalidi I; Villiers S; Giachetti S; Frere C; Farge D
    Cancer Med; 2017 Nov; 6(11):2732-2744. PubMed ID: 28980454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen.
    Chen R; Liu X; Law AD; Kanfar S; Maze D; Chan SM; Gupta V; Yee KW; Minden MD; Schimmer AD; Schuh AC; McNamara CJ; Murphy T; Xu A; Falcone U; Seki J; Sibai H
    Curr Oncol; 2020 Dec; 28(1):128-137. PubMed ID: 33704181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.